Cutaneous Melanoma
📧 Sign up to get email alerts when something new happens for Cutaneous Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Phase 1 Study of PF-08046033 in Advanced Solid Tumors [Phase 1]
Pfizer is evaluating PF-08046033 in a Phase 1 trial for adults with advanced solid tumors, including non-small cell lung cancer, esophageal …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: The Multicentre Selective Lymphadenectomy Trial - 3 [NA]
The multicentre trial evaluating selective lymphadenectomy for stage III cutaneous melanoma is currently recruiting at multiple centers.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma [Phase 3]
Phase 3 clinical trial evaluating SUPRAME-ACTengine IMA203 versus investigator's choice of treatment in previously treated, unresectable or …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating immunotherapy in combination with prednisone and sirolimus for kidney transplant recipients with unresectable or …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating pembrolizumab alone or in combination with CMP-001 for operable melanoma, including melanoma of u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies [Phase 1]
Phase 1 trial update evaluating cediranib maleate and selumetinib sulfate in patients with solid malignancies, including metastatic melanoma…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) [Phase 2]
A Phase 2 trial evaluating Acasunlimab alone and in combination with pembrolizumab for advanced melanoma that has relapsed after prior check…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment [Phase 1, Phase 2]
A Phase 1/2 trial is evaluating whether adding tazemetostat to dabrafenib and trametinib improves outcomes in patients with metastatic melan…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]
A clinical trial update for AU-007, a monoclonal antibody that binds IL-2 and inhibits IL-2Rα binding, being studied in unresectable locally…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Exercise to Boost Response to Checkpoint Blockade Immunotherapy [NA]
Clinical trial update describes an active-not-recruiting study investigating whether exercise can boost response to checkpoint blockade immu…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors [Phase 1]
A Phase 1 trial evaluating donor natural killer cells with cyclophosphamide and etoposide in children and young adults with relapsed or refr…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer [NA]
This clinical trial update notes a study evaluating whether a ketogenic diet can improve response to immunotherapy in patients with metastat…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors [Phase 1]
This update reports on a Phase 1 trial testing the combination of sonidegib and pembrolizumab in patients with various advanced solid tumors…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer [Phase 1]
A Phase 1 clinical trial at MD Anderson Cancer Center is studying whether modifying the gut microbiome via fecal transplantation can reduce …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers [Phase 2]
Phase 2 clinical trial evaluating EMLA Topical Cream to reduce pain from intradermal Tc-99 injections used for lymphoscintigraphy in patient…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma [Phase 1]
Phase 1 trial evaluating an intralesional influenza vaccine for treating stage I-IV cutaneous melanoma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
An ongoing clinical trial is recruiting to study the frequency and clinical phenotype of BAP1 tumor predisposition syndrome and its associat…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Neoadjuvant Atezolizumab in Cutaneous Melanoma [Phase 1]
Phase 1 neoadjuvant trial of atezolizumab in patients with cutaneous melanoma; the study is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases [Phase 2]
Phase 2 trial evaluating stereotactic radiosurgery for patients with more than three melanoma brain metastases; the study is currently activ…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: PRAME Immunohistochemistry-Guided Slow Mohs Micrographic Surgery for the Treatment of Stage 0 to IIc Cutaneous Melanoma [NA]
An ongoing UC Davis-sponsored clinical trial is evaluating PRAME immunohistochemistry-guided slow Mohs micrographic surgery for stage 0 to I…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours [Phase 1]
Phase 1 study of the investigational therapy MBS8(1V270) evaluating safety and preliminary efficacy in patients with advanced solid tumors, …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors [EARLY_Phase 1]
Early-phase clinical trial investigating a radiolabeled anti-PD-L1 single-domain antibody (177Lu-anti-PD-L1 sdAb) in metastatic solid tumors…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) [Phase 2]
A Phase 2 neoadjuvant trial (Neo IRENIE) evaluating a triple combination of ipilimumab, relatlimab, and nivolumab in resectable cutaneous an…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma [NA]
This clinical trial investigates how electrochemotherapy alters the tumor microenvironment in cutaneous melanoma, with recruitment ongoing. …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) [Phase 2]
Clinical trial update for RP1 as a monotherapy and in combination with nivolumab (IGNYTE) in Phase 2 across several cancers; the study is cu…